R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2022
Back to search
Official data from USPTO
OVAR SCREEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
04/29/2022
Trademark type
Combined
Nice classes
5, 10, 42, 44
Filing date
11/05/2020
Registration date
03/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2022
Last transaction
04/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Vienna, AT
Examiner
ADEBAYO, OMOLAYO E.
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the letters "OAR" in red and the word "SCREEN" in black, with "OAR" positioned above and to the left of "SCREEN." The word "SCREEN" and the letters "O", "A", and "R" of "OAR" are in capital letters. A sign in the form of a downwardly pointing triangle is positioned between the letter "O" and the letters "A" and "R" of "OAR" and extends above the letters "O", "A", and "R." All of the aforementioned are on a white background.
Holders and representatives
Holders
OVARTEC GmbH
Representatives
Michael Fedrick LOZA & LOZA, LLP
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical preparations for the treatment of cancer; Medical preparations for use in the field of oncology; Diagnostic preparations for medical use; Diagnostic preparations for medical purposes; Diagnostic test kits consisting primarily of nucleic acid sequences or moleculesbuffersreagentsassays for use in disease testing; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing of fluid or tissue samples of patients for the diagnosis of cancer; Medical diagnostic reagents; Clinical medical reagents; Nucleic acid sequences and chemical reagents for medical purposes
Class 10
Medical instruments and apparatus for obtaining and testing fluid or tissue samples of patients for diagnosing cancer; Diagnostic test kits consisting primarily of probesbuffers and reagents for analyzing cells for determination of cancer
Class 42
Development of therapies for the treatment of cancer
Class 44
Medical servicesin particular medical analysis in the field of oncology; Medical diagnostic testing services in the field of oncology
Publications
History of USPTO decisions and trademark events.
17 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/21/2021
PUBO
PUBLISHED FOR OPPOSITION
12/21/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/01/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
11/16/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/12/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/21/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/20/2021
GNRT
NON-FINAL ACTION E-MAILED
04/20/2021
CNRT
NON-FINAL ACTION WRITTEN
04/20/2021
DOCK
ASSIGNED TO EXAMINER
04/12/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/05/2021
NWAP
NEW APPLICATION ENTERED
11/09/2020
Continuous trademark protection
Get notified about every new filing that threatens OVAR SCREEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.